The amelioration on the vascular inflammatory response by evogliptin, a novel dipeptidyl peptidase 4 inhibitor via regulation of SIRT1/NF-KAPPAB interaction. (August 2018) - Cho, M.K.; Nguyen, P.A.; Won, J.S.; Bae, E.J.